New Delhi, May 4 Ranbaxy Laboratories Ltd on Monday announced the commencement of the third phase clinical trials for its new anti-malaria combination drug in India, Bangladesh and Thailand.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/ranbaxy-close-completing-trials-new-malaria-drug
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-line-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-borne-diseases
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/thailand
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ranbaxy-pharmaceuticals